Fundraising FoxAstrocyte Pharmaceuticals
Groton, US · Delaware corporation · 11 known investors
Find your way into Astrocyte Pharmaceuticals
Sign up to see every warm intro you have to Astrocyte Pharmaceuticals
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Astrocyte Pharmaceuticals team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Cloudflare provides web performance and security infrastructure solutions, helping websites optimize speed and protect against threats and malicious traffic.
Founders & leadership
Investors · 11
How we know: funding news · astrocytepharma.com · Not right? Tell us
Also in the syndicate · 8
Funding
SEC filings, press & company announcements$12.8M disclosed across 3 of 4 rounds · 2017–2023
- Undisclosed amountpre-Series B BridgeAug 2023
Dreavent Capital (lead), Alzheimer's Drug Discovery Foundation, Boston Harbor Angels, DeepWork Capital, Life Science Angels, Mass Medical Angels, Mid Atlantic Bio Angels, Navis VB Fund I, SideCar Angels, Trend Investment Group
Source ↗
▶$2.8MraisedOct 2022 · 48 investors · PharmaceuticalsRule 506(b)
- William S. KorinekExecutive Officer, Director
- Christine GallagherDirector
- Jeffrey IvesDirector
- Jeffrey ArnoldDirector
- Jackson StreeterDirector
- Offering amount
- $5M
- Amount sold
- $2.8M
- First sale
- Oct 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$7.5MraisedDec 2020 · 70 investors · PharmaceuticalsRule 506(b)
- Jeffrey ArnoldDirector
- Jeffrey IvesDirector
- William KorinekExecutive Officer, Director
- Offering amount
- $8.7M
- Amount sold
- $7.5M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.4MraisedJul 2017 · 46 investors · Other Health CareRule 506(b)
- James D. LechleiterDirector
- William KorinekExecutive Officer, Director
- Jeffrey L. IvesDirector
- Offering amount
- $2.4M
- Amount sold
- $2.4M
- First sale
- Mar 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 1
Companies working in the same space as Astrocyte Pharmaceuticals.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2018 | $3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $297.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2015 | $671.7K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders | The Manila Timesmanilatimes.net · Aug 2026Frequently asked questions
- What does Astrocyte Pharmaceuticals do?
- Cloudflare provides web performance and security infrastructure solutions, helping websites optimize speed and protect against threats and malicious traffic.
- Who are Astrocyte Pharmaceuticals's investors?
- Astrocyte Pharmaceuticals's investors include Boston Harbor Angels, UT Horizon Fund, DeepWork Capital.
- How much funding has Astrocyte Pharmaceuticals raised?
- Astrocyte Pharmaceuticals has disclosed $12.8M raised across 3 of its 4 known rounds.
- Where is Astrocyte Pharmaceuticals headquartered?
- Astrocyte Pharmaceuticals is headquartered in Groton, US.